Droga research grant is an annual research grant that is organized by Droga Pharma PLC in the thematic areas of:
- API Discovery & Excipient Characterization
- Herbal Medicine
- Food Supplements & Nutraceuticals
- Formulation Development
- Cosmetics
For the past four years, the grant has been awarded to the following four researchers:
- Evaluation of the hypolipidemic effect of leaf extract of Lippia Adoensis Koseret in hypercholesterolemic mice: granted 71,984.00ETB
- Exploration of Spirulina (Arthrospira Fusiformis) and Oyster Mushroom Formulation as Potential Nutraceuticals for improved Nutrition and Better Human Health: granted 100,000.00ETB
- Effect of replacement of Wheat with fava bean and black cumin flours on nutritional properties and sensory attributes of bread: granted 62,800.00ETB
- Formulation, In-Vitro evaluation & optimization of milk-based oral dispersible Griseofulvin tablets prepared by direct compression method: granted 90,750.00ETB
- Formulation design and physicochemical evaluation of Diabetic foot care emollient, A way to tackle diabetic foot xerosis (DFX): granted 89,400 ETB
Now, Droga Pharma PLC announces the 2026 Droga Research Grant, in the following selected thematic areas:
- Formulation Development for Dermatological Products
Please visit https://drogapharma.com/r-d/ for details regarding eligibility criteria and how to apply to the DRG-2026